Eribulin monotherapy in heavily pretreated metastatic breast cancer patients in real life

Abstract

Background and Aim: Our retrospective, single-center study aimed at evaluating the efficacy and safety of eribulin in heavily pretreated metastatic breast cancer (MBC) in routine clinical practice.